Literature DB >> 22505288

Exercise training in juvenile dermatomyositis.

Clarissa Harumi Omori1, Clovis Artur Almeida Silva, Adriana Maluf Elias Sallum, Rosa Maria Rodrigues Pereira, Ana Lúciade Sá Pinto, Hamilton Roschel, Bruno Gualano.   

Abstract

OBJECTIVE: To investigate the effects of a supervised exercise training program on health parameters, physical capacity, and health-related quality of life in patients with mild and chronic juvenile dermatomyositis (DM).
METHODS: This was a prospective longitudinal study following 10 children with mild and chronic juvenile DM (disease duration >1 year). The exercise program consisted of twice-a-week aerobic and resistance training. At baseline and after the 12-week intervention, we assessed muscle strength and function, aerobic conditioning, body composition, juvenile DM scores, and health-related quality of life.
RESULTS: Child self-report and parent proxy-report Pediatric Quality of Life Inventory scores were improved after the intervention (-40.3%; P = 0.001 and -48.2%; P = 0.049, respectively). Importantly, after exercise, the Disease Activity Score was reduced (-26.9%; P = 0.026) and the Childhood Muscle Assessment Scale was improved (+2.5%; P = 0.009), whereas the Manual Muscle Test presented a trend toward statistical significance (+2.2%; P = 0.081). The peak oxygen consumption and time-to-exhaustion were increased by 13.3% (P = 0.001) and 18.2% (P = 0.003), respectively, whereas resting heart rate was decreased by 14.7% (P = 0.006), indicating important cardiovascular adaptations to the exercise program. Upper and lower extremity muscle strength and muscle function were also significantly improved after the exercise training (P < 0.05). Both the whole-body and the lumbar spine bone mineral apparent density were significantly increased after training (1.44%; P = 0.044 and 2.85%; P = 0.008, respectively).
CONCLUSION: We showed for the first time that a 12-week supervised exercise program is safe and can improve muscle strength and function, aerobic conditioning, bone mass, disease activity, and health-related quality of life in patients with active and nonactive mild and chronic juvenile DM with near normal physical function and quality of life.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22505288     DOI: 10.1002/acr.21684

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  15 in total

Review 1.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

Review 2.  Physical activity for paediatric rheumatic diseases: standing up against old paradigms.

Authors:  Bruno Gualano; Eloisa Bonfa; Rosa M R Pereira; Clovis A Silva
Journal:  Nat Rev Rheumatol       Date:  2017-05-23       Impact factor: 20.543

Review 3.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 4.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

Review 5.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

Review 6.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 7.  Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation.

Authors:  Fabiana B Benatti; Bente K Pedersen
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

8.  Safety and feasibility of maximal physical testing in rheumatic diseases: a cross-sectional study with 5,910 assessments.

Authors:  Rodrigo Branco Ferraz; Bruno Gualano; Carlos Merege Filho; Murilo Groschitz Almeida; Luiz Augusto Perandini; Thalita Dassouki; Ana Lúcia Sá-Pinto; Fernanda Rodrigues Lima; Hamilton Roschel
Journal:  Rheumatol Int       Date:  2014-11-06       Impact factor: 2.631

Review 9.  Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

Authors:  Emily von Scheven; Kathleen Jo Corbin; Stefano Stagi; Stagi Stefano; Rolando Cimaz
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

10.  Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus.

Authors:  Ana Jéssica Pinto; Hamilton Roschel; Fabiana Braga Benatti; Ana Lúcia de Sá Pinto; Adriana Maluf Elias Sallum; Clóvis Arthur Silva; Bruno Gualano
Journal:  Clin Rheumatol       Date:  2016-03-28       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.